Let’s clear this up: your back office isn’t an office. It’s the system you build to make decisions, protect your money, and stay on the road legally. It doesn’t need to be big—but it does need to be ...

Stock dividend issued to IMUNON shareholders reflects confidence in clinical programs, long-term growth strategy and dedication to rewarding shareholders. First patient dosed in P ...

ZUG, Switzerland, August 5, 2025 – MoonLake Immunotherapeutics (NASDAQ:MLTX) (“MoonLake” or the “Company”), a clinical-stage biotechnology company focused on creating next-level therapies for ...